MAFZoledronic Acid Infusion 5 mg/100 mL
1) For patients with osteoporosis (T score ≤ -2.5) and who are unable to tolerate or follow the administration instructions for oral bisphosphonates
2) For patients with FRAX of ≥ 20 for major osteoporotic fractures and ≥ 3 for hip fractures and who are unable to tolerate or follow the administration instructions for oral bisphosphonates